Multivariate Analysis of Risk of Treatment Failure in Childhood B-Precursor ALL Patients With Satisfactory Ploidy and Immunophenotypic Studies (N = 1,211)
| Adverse Variable . | P . | Estimated Risk Ratio . |
|---|---|---|
| . | . | (95% confidence limits) . |
| NCI poor-risk group | <.001 | 2.1 (1.5-2.9) |
| DNA < 1.16 | .009 | 1.7 (1.1-2.4) |
| Brightest-quartile CD45 | <.001 | 1.9 (1.4-2.6) |
| Brighter than 1st-quartile CD20 | .004 | 1.5 (1.1-1.9) |
| Adverse Variable . | P . | Estimated Risk Ratio . |
|---|---|---|
| . | . | (95% confidence limits) . |
| NCI poor-risk group | <.001 | 2.1 (1.5-2.9) |
| DNA < 1.16 | .009 | 1.7 (1.1-2.4) |
| Brightest-quartile CD45 | <.001 | 1.9 (1.4-2.6) |
| Brighter than 1st-quartile CD20 | .004 | 1.5 (1.1-1.9) |